Press Releases

Mar 07, 2012
Professor Vincenzo Di Marzo to direct GW’s global pre-clinical research programme Porton Down, UK; 8 March 2012: GW Pharmaceuticals plc (AIM: GWP) today announces that, effective March 1st 2012, Professor Vincenzo Di Marzo has agreed to direct GW’s global pre-clinical research programme and will
Feb 06, 2012
Sativex regulatory approval received in Austria Porton Down, UK; 7 February 2012: GW Pharmaceuticals plc (AIM: GWP) today announces a regulatory update for Sativex® (Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) oromucosal spray. Sativex ® has received regulatory approval in Austria as a